Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Hutchison China Meditech Limited $282 Million Secondary Offering
Davis Polk advised the underwriter in connection with a secondary offering of 12,000,000 American Depositary Shares of…
Medtronic Global Holdings S.C.A. €5 Billion Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €5…
Davis Polk Advises McKesson on Change Healthcare’s Initial Public Offering and Concurrent Equity Units Offering
Davis Polk advised McKesson Corporation on Change Healthcare Inc.’s SEC-registered initial public offering of 49,285,713…
Gamida Cell Ltd. $35 Million Follow-On Offering
Davis Polk advised the underwriters in connection with the $35 million SEC-registered follow-on offering of ordinary shares…
The Medicines Company $172.5 Million Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by The Medicines Company of 5,227…
Davis Polk Advises Notre Dame Intermédica on Its R$2.7 Billion Equity Offering
Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Bain Capital, the…
Atreca $125 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $125 million initial public…
Personalis, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $155 million…
Stoke Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of…
Orchard Therapeutics plc Approximately $128 Million Follow-On Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the…